Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study-Reference-Cited by-同舟云学术

Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study

Published:2023-09 Issue: Volume:109 Page:65-74
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Bae Charles J.,Zee Phyllis C.,Leary Eileen B.,Fuller Douglas S.,Macfadden Wayne,Candler Shawn,Steininger Teresa L.,Husain Aatif M.

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. The international classification of sleep disorders,2014

2. The international classification of sleep disorders,2014

3. Xyrem® (sodium oxybate) oral solution, CIII [prescribing information],2022

4. Declaring the sodium content of drug products;Szarfman;N Engl J Med,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study;Journal of Clinical Sleep Medicine;2024-09

2. Cardiovascular Risks in People With Narcolepsy: Expert Panel Consensus Recommendations;Journal of the American Heart Association;2024-08-20

3. Corrigendum to “Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study” [Sleep Med. 109 (2023) 65–74 ISSN 1389–9457];Sleep Medicine;2024-07

4. Impaired cognition in narcolepsy: clinical and neurobiological perspectives;SLEEP;2024-06-29

5. Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations;Neurology and Therapy;2024-04-25